Spectrum Pharmaceuticals Reports First Quarter 2023 Financia

-- Q1 2023 net sales of $15.6 million, an increase of 54% compared to Q4 2022 --


-- Company to be acquired by Assertio Holdings, Inc., delivering value to stakeholders in an all stock and... | May 9, 2023

Related Keywords

Russia , Ukraine , , Nasdaq , Securities Exchange , Assertio Holdings Inc , Spectrum Investor Relations Department , Spectrum Pharmaceuticals , Nuclear Imaging , Assertio Investor Relations Department , Spectrum Pharmaceuticals Inc , Recent Business , Assertio Holdings , Tom Riga , Chief Executive Officer , Quarter Ended March , Continuing Operations , Respiratory Distress Syndrome , Cell Crisis , Sickle Cell , Tumor Growth Stimulatory Effects , Acute Myeloid Leukemia , Securities Act , Securities Exchange Act , Annual Reports , Quarterly Reports , Current Reports , Investor Relations Department , Annual Report , Proxy Statement , Spectrum Pharmaceutical , Consolidated Statements , Nc Stock Exchange , News , Information , Press Release , 1 , 023 , Pet , Sales , F , N , Increase , Ompared , O , 4 , 022 , Company , The , Cquired , Y , Assertio , Elivering , Value , Stakeholders , Wall , Tock Sppi Us84763a1088 ,